The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...

Scientific research has gifted us with a range of evidence-based options to protect ourselves from getting infected with HIV.

The new HIV PrEP option could drastically reduce the number of new cases by offering a new alternative to daily pills or ...

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.

The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...

New study shows cheap HIV drug lamivudine helps diabetic macular edema, improving vision. Oral option could replace eye ...

Lenacapavir is a major step forward in HIV prevention. With just two injections a year, it is a simple and highly effective ...

While PrEP tablets are already prescribed around the world to prevent people from contracting HIV, experts in the US hope a ...

Some people can't pay for the medications, and others don't want to stay on them because of side effects, such as nausea, diarrhea, and dizziness. But if you quit treatment, the virus usually ...